Perrigo (PRGO)
NYSEHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-09-04
NYSEHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-09-04
QuarterlyIQ Insights · PRGO
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Results of Operations and Financial Condition On August 5, 2026, Perrigo Company plc (the “Company”) released earnings for the second quarter ended June 27, 2026. The press release related to the Company’s earnings is attached as Exhibit 99.1. The Company provides non-GAAP financial measures as additional information that it believes is useful to investors and analysts in evaluating the performance of the Company's ongoing operating trends, facilitating comparability between periods and, wher…
Interim President and Chief Executive Officer — Albert A. Manzone: Mr. Manzone was appointed as the Interim President and Chief Executive Officer with detailed compensatory arrangements.
The company reinstated a severance policy for its executive officers.
Director — Salman Amin, Omer Gajial: Two new directors were appointed to the Board of Directors.
President and Chief Executive Officer — Patrick Lockwood-Taylor: Resigned due to personal conduct inconsistent with the Company's Code of Conduct and core values.
Results of Operations and Financial Condition On May 6, 2026, Perrigo Company plc (the “Company”) released earnings for the first quarter ended March 28, 2026. The press release related to the Company’s earnings is attached as Exhibit 99.1. The Company provides non-GAAP financial measures as additional information that it believes is useful to investors and analysts in evaluating the performance of the Company's ongoing operating trends, facilitating comparability between periods and, where a…
Annual board election with no specific departures or promotions mentioned.
of Form 8-K. 104 Cover Page Interactive Data file (embedded within the Inline XBRL document). * The Company has omitted certain schedules and other similar attachments to such agreement pursuant to Item 601(b) of Regulation S-K. The Company will furnish a copy of such omitted documents to the SEC upon request. † Pursuant to Item 601(b)(2)(ii) of Regulation S-K, certain portions of this exhibit have been redacted because the Company customarily and actually treats such omitted information as p…
Completion of Acquisition of Disposition of Assets. As previously disclosed, on July 13, 2025, Perrigo Company plc (the “Company”) entered into a Master Sale and Purchase Agreement (the “Agreement”) with Kairos Bidco AB (“Kairos”), an affiliate of Karo Healthcare AB (“Karo”) and an investment vehicle managed by an affiliate of KKR & Co., Inc. (“KKR”), pursuant to which, and subject to the terms and conditions set forth therein, the Company agreed to sell and Karo agreed to acquire (1) all of…
Regulation FD Disclosure On February 26, 2026, Perrigo Company plc (the “Company”) announced a change to its reporting segments to align with its organizational structure and vision. As part of this update, which was implemented as of the first quarter 2026, the Company has transitioned from a geographic segment reporting structure to one that is product category based, enabling the Company to better align its financial disclosures and operational analysis with the Company's product offerings…
and 7.01 of Form 8-K. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. (Registrant) PERRIGO COMPANY PLC By: /s/ Eduardo Bezerra Dated: April 22, 2026 Eduardo Bezerra Chief Financial Officer
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth in
Entry into a Material Definitive Agreement. As previously disclosed, on April 20, 2022, Perrigo Company plc, a public limited company organized under the laws of Ireland (the “Company”), and Perrigo Investments, LLC, a Delaware limited liability company (“Perrigo Investments”), entered into a Credit Agreement by and among the Company, Perrigo Investments, the other subsidiaries of the Company named therein, JPMorgan Chase Bank, N.A., as administrative and collateral agent, and the other lende…
Results of Operations and Financial Condition On February 26, 2026, Perrigo Company plc (the “Company”) released earnings for the fourth quarter ended December 31, 2025. The press release related to the Company’s earnings is attached as Exhibit 99.1. The Company provides non-GAAP financial measures as additional information that it believes is useful to investors and analysts in evaluating the performance of the Company's ongoing operating trends, facilitating comparability between periods an…
Results of Operations and Financial Condition On November 5, 2025, Perrigo Company plc (the “Company”) released earnings for the third quarter ended September 27, 2025. The press release related to the Company’s earnings is attached as Exhibit 99.1. The Company provides non-GAAP financial measures as additional information that it believes is useful to investors and analysts in evaluating the performance of the Company's ongoing operating trends, facilitating comparability between periods and…
Regulation FD Disclosure On November 5, 2025, the Company issued a press release announcing that it is initiating a strategic review of its infant formula business, a copy of which is furnished as Exhibit 99.2 and is incorporated herein by reference. The information contained in this paragraph, as well as Exhibit 99.2 referenced herein, shall not be deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that Section. The information contained…
Results of Operations and Financial Condition On August 6, 2025, Perrigo Company plc (the “Company”) released earnings for the second quarter ended June 28, 2025. The press release related to the Company’s earnings is attached as Exhibit 99.1. The Company provides non-GAAP financial measures as additional information that it believes is useful to investors and analysts in evaluating the performance of the Company's ongoing operating trends, facilitating comparability between periods and, wher…
Entry into a Material Definitive Agreement On July 13, 2025, Perrigo Company plc (the “Company”) entered into a Master Sale and Purchase Agreement (the “Agreement”) with Kairos Bidco AB (“Kairos”), an investment vehicle managed by an affiliate of KKR & Co., Inc. (“KKR”), pursuant to which, and subject to the terms and conditions set forth therein, the Company agreed to sell and Kairos agreed to acquire (1) all of the shares in Aco Hud Nordic AB, a Swedish private corporation ( aktiebolag ) (t…
of Form 8-K. 104 Cover Page Interactive Data file (embedded within the Inline XBRL document). * The Company has omitted certain schedules and other similar attachments to such agreement pursuant to Item 601(b) of Regulation S-K. The Company will furnish a copy of such omitted documents to the SEC upon request. † Pursuant to Item 601(b)(2)(ii) of Regulation S-K, certain portions of this exhibit have been redacted because the Company customarily and actually treats such omitted information as p…
EVP & President, Consumer Self-Care Americas — Catherine “Triona” Schmelter: The departure was due to the elimination of the position via mutual agreement, which is a standard organizational restructuring rather than a sudden loss of a top-tier executive like the CEO or CFO.
Executive Vice President — Ronald Janish: The filing discloses a planned, mutually agreed retirement of an EVP with a defined transition period and severance, representing an orderly succession rather than a sudden loss of executive leadership.
Results of Operations and Financial Condition On May 7, 2025, Perrigo Company plc (the “Company”) released earnings for the first quarter ended March 29, 2025. The press release related to the Company’s earnings is attached as Exhibit 99.1. The Company provides non-GAAP financial measures as additional information that it believes is useful to investors and analysts in evaluating the performance of the Company's ongoing operating trends, facilitating comparability between periods and, where a…
Results of Operations and Financial Condition On February 27, 2025, Perrigo Company plc (the “Company”) released earnings for the fourth quarter ended December 31, 2024. The press release related to the Company’s earnings is attached as Exhibit 99.1. The Company provides non-GAAP financial measures as additional information that it believes is useful to investors and analysts in evaluating the performance of the Company's ongoing operating trends, facilitating comparability between periods an…
CEO — Patrick Lockwood-Taylor: The filing discloses the extension of the CEO's employment agreement and compensation terms, which is a routine contractual update rather than a change in personnel or a departure.
Director — Katherine Doyle: The filing discloses the planned retirement of an independent director at the upcoming annual meeting, which is a routine board succession event rather than a sudden executive departure.
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.